checkAd

     334  0 Kommentare Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Mexico - Seite 3

    CONTACT:   

    Matthew Beck
    mbeck@troutgroup.com
    The Trout Group
    (646) 378-2933




    This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: Apricus Biosciences, Inc. via Globenewswire


    GlobeNewswire
    0 Follower
    Autor folgen
    Seite 3 von 3
    Verfasst von GlobeNewswire
    Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Mexico - Seite 3 Ferring Plans to Launch in Mexico and Argentina During the Second Quarter 2017 SAN DIEGO, Jan. 18, 2017 (GLOBE NEWSWIRE) - Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and …